| Independently reported | |
| Health tourists (2015) | 10,423, claimed by the government tourism and foreign investment agency ProColombia, a 6.4 per cent increase on 9,792 in 2014[1] |
|---|---|
| Earlier government agency claims | 20,000 to 50,000 medical tourists a year[1] |
| Counting method | A mix of official incoming traveller data and the agency’s own calculations[1] |
| Recorded source countries (2015) | Netherlands 4,492, United States 1,159, Venezuela 860, Ecuador 628, Panama 625[1] |
| Known limitation | The figures may include people seeking urgent, unplanned medical treatment[1] |
| Specialties promoted | Assisted reproduction, oncology, urology, physical rehabilitation and cardiology, plus wellness services[1] |
| South America in United States outbound health travel | 26 per cent of destinations[3] |
| Medical tourism in the health system country profile | Not mentioned[4] |
| This entry has no primary-record band. No ProColombia publication was read directly; its figures reach this entry through a trade publication report from April 2016, so they are second-hand and a decade old. The agency that produced them promotes Colombian exports, and the figures are partly its own calculations rather than a statistical series. No revenue figure was given. No typical cost range is given. | |
Medical tourism in Colombia is documented by a government promotion agency whose own figure of 10,423 health tourists in 2015 sits an order of magnitude below earlier official claims of 20,000 to 50,000 a year. The lower figure is the more credible one, and it has its own problem: 43 per cent of it is attributed to the Netherlands, which the trade publication reporting it could not explain.
The figures
A report published on 18 April 2016 records that ProColombia, the government tourism and foreign investment agency, claimed 10,423 health tourists in 2015, a 6.4 per cent increase on 9,792 in 2014. The data is described as coming from a mix of official incoming traveller records and ProColombia calculations. By source country the agency gave the Netherlands at 4,492, the United States at 1,159, Venezuela at 860, Ecuador at 628 and Panama at 625.[1]
ProColombia described Colombia as attractive for assisted reproduction, oncology, urology, physical rehabilitation and cardiology, and said its medical tourism includes wellness services. No numbers by treatment type and no revenue figure were given.[1]
Why the smaller number is the better one
The report treats the figure of around 10,000 as reasonable precisely because it is so much lower than the 20,000 to 50,000 that government agencies had previously claimed. That judgement is worth endorsing. A promotion agency publishing a number that undercuts its predecessors by a factor of two to five is behaving unusually, and in the direction that argues for taking it seriously.[1]
The report also flags what it calls the usual problem: the figures may include people seeking urgent, unplanned medical treatment. That matters for interpretation rather than accuracy. A tourist who breaks an ankle and is treated in Bogota has received healthcare in Colombia but did not travel there for it, and counting such cases inflates a destination’s apparent medical travel sector with incidents that have nothing to do with it.[1]
The Dutch anomaly
The single largest recorded source country is the Netherlands, at 4,492 of 10,423, or 43 per cent of the total. The report’s author found this harder to explain, noting that few Dutch tourists visit Colombia.[1]
One possible explanation, which the source does not offer and which is therefore not a finding here, is that Dutch nationality extends to residents of Aruba, Curacao and Bonaire, which lie off the Colombian coast and whose residents would be recorded as Dutch nationals in arrival data. If so the figure would describe short-haul cross-border care from the southern Caribbean rather than long-haul travel from Europe. The point is raised only to show that a 43 per cent share of a national total can rest on a nationality classification rather than on a patient flow, and that the record as it stands does not say which.
Until that is resolved, the usable part of the Colombian figure is the remainder. Setting the Dutch entry aside leaves about 5,900 patients, of whom the United States supplies under 1,200 and the rest come overwhelmingly from Venezuela, Ecuador and Panama. On that reading Colombia is primarily a regional destination for its immediate neighbours rather than a long-haul one, which is a materially different proposition from the way it is usually marketed.
Regional and system context
A 2015 briefing by an economist in the United States International Trade Commission’s Office of Industries, published as the author’s own views and not the Commission’s, records South America as 26 per cent of destinations for outbound United States health travellers, with the Caribbean at 19 per cent and Central America at 18 per cent, and gives the global estimate of roughly 3 million patients travelling for healthcare each year.[3]
The Centers for Disease Control and Prevention names several South American countries among the most common destinations for United States medical tourists, lists cosmetic surgery, dental care, cancer treatment, fertility treatment and organ transplantation as the procedures most often sought, and states that accreditation does not guarantee a good outcome.[2]
A country profile of Colombia’s health and pharmaceutical systems, organised into pharmaceutical system domains and drawing on the national medicines regulator, the health ministry, the World Bank, the World Trade Organization and WHO, does not mention medical tourism, health tourism or foreign patients. It records data gaps in standard treatment guidelines, procurement and reimbursement, medical device regulation, radiological safety regulatory infrastructure and blood services, and notes that medicines are often paid out of pocket because they are not in many benefit packages.[4]
Limits of the evidence
No ProColombia publication, Colombian health ministry statistic or national statistics office series was read directly, so the central figures are second-hand and a decade old. The profile consulted gives no Colombian health spending, bed, workforce or coverage figures and does not name its publisher on the page, though its references to internal data indicate a regional health organisation. Whether ProColombia has published later figures, and whether the Dutch entry was ever explained, could not be established. Nothing has been estimated, and the arithmetic in this entry that sets the Dutch entry aside is identified as a reading of the published figures rather than a corrected count.
See also
- Source markets in medical tourism, and what a nationality classification can hide
- Emergency healthcare abroad, which these figures may include
- Medical tourism in Ecuador, one of the recorded source countries
- International patient visits and unique patients, the counting problem behind the older claims
- Medical tourism statistics, and a rare downward revision
References
- International Medical Travel Journal. Latest medical tourism figures from Colombia. Published 18 April 2016. Independently reported: the report was opened and the figure of 10,423 health tourists in 2015 claimed by ProColombia described as the government tourism and foreign investment agency, the 6.4 per cent increase on 9,792 in 2014, the statement that the data comes from a mix of official incoming traveller records and ProColombia calculations, the source country breakdown of Netherlands 4,492, United States 1,159, Venezuela 860, Ecuador 628 and Panama 625, ProColombia’s identification of assisted reproduction, oncology, urology, physical rehabilitation and cardiology as attractive specialties together with wellness services, the absence of any revenue figure or treatment-type numbers, the caveat that health tourist figures may include people seeking urgent unplanned medical treatment described as the usual problem, the assessment that the figure of around 10,000 is reasonable compared with earlier government agency claims of 20,000 to 50,000 medical tourists a year, and the author’s statement that the high Dutch figure is harder to explain since few Dutch tourists visit Colombia were read directly. Retrieved 23 October 2026.
- Stoney, R. J. and Leidel, L. Medical Tourism. CDC Yellow Book: Health Information for International Travel, 2026 edition, United States Centers for Disease Control and Prevention. Page dated 23 April 2025. Independently reported: the chapter was opened and the naming of several South American countries alongside Mexico, Canada and the Caribbean as the most common destinations for United States medical tourists, the listing of cosmetic surgery, dental care, cancer treatment, fertility treatment and organ transplantation as the procedures most often sought, and the statement that accreditation does not guarantee a good outcome were read directly. Retrieved 23 October 2026.
- Chambers, A. Trends in U.S. Health Travel Services Trade. Office of Industries, United States International Trade Commission, Executive Briefing on Trade, August 2015. Independently reported: the briefing was opened and the 2011 outbound destination shares of South America 26 per cent, Caribbean 19 per cent and Central America 18 per cent, and the global estimate that roughly 3 million patients are thought to travel for healthcare each year, were read directly. The briefing states that the views expressed are those of the author and not those of the Commission. Retrieved 23 October 2026.
- Colombia country profile: health and pharmaceutical systems. Independently reported: the profile was opened and its description as a profile of health and pharmaceutical system structures and performance forming an input to a larger dashboard project, its organisation of pharmaceutical system indicators into 13 domains drawing on the national medicines regulator, the health ministry, the single window for foreign trade, the World Bank, the World Trade Organization and WHO, its recorded data gaps in standard treatment guidelines, procurement and reimbursement, medical device regulation, radiological safety regulatory infrastructure and blood services, its statement that medicines are often paid out of pocket because they are not in many benefit packages, the absence of any figures for health spending, out-of-pocket share, beds, physicians, nurses, coverage or population, and the absence of any reference to medical tourism, health tourism or foreign patients were read directly. The page does not name its publisher, though its references to internal data and to previous country profiles indicate a regional health organisation. Retrieved 23 October 2026.
Sourcing note: the possible explanation offered for the Dutch entry is explicitly labelled as not coming from any source, because inventing a reason for an anomaly is worse than naming it. The arithmetic setting that entry aside is presented as a reading of the published numbers, not as a corrected figure. The entry endorses ProColombia’s lower figure over earlier official claims and says why, rather than reporting both as equally valid. Nothing has been estimated.